Summary
1. Skin Cancer
NCT05323253
Update：2025-12-02
Objective："pivotal study"
Condition ：cutaneous squamous cell carcinoma
Primary/Study Completion：2025-12＊
Enrollment：86＊
Locations：US25 Canada1 Israel4
2. Oral Cavity Cancer
#1 NCT05047094
Condition：Recurrent unresectable or metastatic Head and Neck Squamous Cell Carcinoma
Update：2025-12-02
Objective：futility or efficacy
Primary Completion：2026-12＊
Study Completion：2027-06＊
Enrollment：48＊
Locations：Israel3
#2 NCT03889899
Conditions：superficial cutaneous, mucosal or soft tissue neoplasia
Update：2025-12-02
Objective：safety and efficacy
Primary/Study Completion：2026-09＊
2026-09＊
Enrollment：30＊
Location：Israel1
3. Breast Cancer
NCT06202118
Update：2025-02-07
Objective：Feasibility and Safety
Condition：frail or elderly with newly diagnosed or recurrent breast carcinoma.
Primary Completion：2026-01＊
Study Completion：2026-06＊
Enrollment：10＊
Locations：Israel3
4. Pancreatic Cancer
#1 NCT04002479
Update：2025-12-02
Objective：safety and efficacy
Condition：advanced pancreatic cancer
Primary /Study Completion：2026-10＊
Enrollment：37
Locations：Canada2
#2 NCT06698458
Conditions：locally advanced pancreatic cancer & metastatic pancreatic cancer
Update：2025-12-02
Objective：feasibility, safety and preliminary efficacy
Primary Completion:2026-10＊
Study Completion：2026-12＊
Enrollment 30＊
Locations：US12 Canada1 Israel1
5. Prostate Cancer
NCT04543903（Completed）
6. Liver Cancer
NCT05829291
condition：Liver Metastases
Update：2024-05-10
Objective：feasibility and safety
Primary Completion 2025-02＊
Study Completion 2026-02＊
Enrollment 10＊
Locations：Canada1
7. Lung Cancer
NCT05632913
Condition：recurrent Lung Cancer
Update 2025-12-02
Objective：Feasibility and Safety
Primary/Study Completion 2027-02＊
Enrollment 10＊
Location：Israel1
8. Brain Tumor
NCT06910306
Condition：recurrent glioblastoma
Update：2025-12-05
objective：Feasibility and Safety
Primary Completion：2026-11-01＊
Study Completion：2026-12-01＊
Enrollment：10＊
Location：US1
＊ Estimated
投資の参考になりましたか？
